ClinicalTrials.Veeva

Menu

Mortality and Muscle Mass Loss in Critically Ill Patients. (MUSIC 2)

B

Brno University Hospital

Status

Not yet enrolling

Conditions

Mortality
Muscle Loss

Study type

Observational

Funder types

Other

Identifiers

NCT07280039
CT0022025

Details and patient eligibility

About

The aim of the study is to monitor changes in muscle mass in critically ill patients and to verify whether a decrease in muscle mass of ≥10% during the first 7 days of hospitalization is associated with increased 28-day mortality. We will be used ultrasoud for measurement the rectus femoris cross sectional area.

Full description

All patients will be admitted to participating ICU centers from December 2025 to December 2026 will be screened and enrolled based on the inclusion and exclusion criteria. Informed consent will be requested. Ultrasound measurements will be performed by the same investigator within the first 24h after ICU admssion and again on day 7 of the patient´s ICU stay. All patient data will be entered into case report form by a study physician. In the follow-up will be determined 28 mortality.

Enrollment

386 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age ≥18 years
  • mechanical ventilation expected for at least 48 hours

Exclusion criteria

  • Clinical Frailty Score above 7 prior admission

  • Neuromuscular disease in previous medical history

  • Amputated lower extremities

  • Trauma of lower extremities involving tights

  • Conditions affecting the nervous system with involvement of the thigh muscle

  • Inability to cooperate during ultrasound examination

  • Inability to perform ultrasound examination on day 7

    9. Inability to perform ultrasound examination on day 7

Trial contacts and locations

1

Loading...

Central trial contact

Jana Fialová, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems